Gingival Crevicular Fluid, Serum Levels of Receptor Activator of Nuclear Factor-Kappa B Ligand, Osteoprotegerin, Interleukin-17 in Rheumatoid Arthritis and Osteoporosis Patients With Periodontal Disease (original) (raw)
Related papers
Absence of αvβ6 Integrin Is Linked to Initiation and Progression of Periodontal Disease
The American Journal of Pathology, 2008
Integrin ␣v6 is generally not expressed in adult epithelia but is induced in wound healing, cancer, and certain fibrotic disorders. Despite this generalized absence, we observed that ␣v6 integrin is constitutively expressed in the healthy junctional epithelium linking the gingiva to tooth enamel. Moreover, expression of ␣v6 integrin was down-regulated in human periodontal disease, a common medical condition causing tooth loss and also contributing to the development of cardiovascular diseases by increasing the total systemic inflammatory burden. Remarkably, integrin 6 knockout mice developed classic signs of spontaneous, chronic periodontal disease with characteristic inflammation, epithelial down-growth, pocket formation, and bone loss around the teeth. Integrin ␣v6 acts as a major activator of transforming growth factor-1 (TGF-1), a key anti-inflammatory regulator in the immune system. Co-expression of TGF-1 and ␣v6 integrin was observed in the healthy junctional epithelium. Moreover, an antibody that blocks ␣v6 integrin-mediated activation of TGF-1 initiated inflammatory periodontal disease in a rat model of gingival inflammation. Thus, ␣v6 integrin is constitutively expressed in the epithelium sealing the gingiva to the tooth and plays a central role in protection against inflammatory periodontal disease through activation of TGF
Histology and histopathology, 2017
Periodontal disease with its systemic implications is highly prevalent among the population, and this correlation could have an impact on the quality lives of many humans. The purpose of this study was to assess the clinical and histopathological changes of the periodontium correlated with the systemic inflammatory response in periodontal disease. An experimental study was performed on male Wistar rats which were subjected to a procedure of periodontitis induction through placing silk thread ligatures around the lower incisors, under general anesthesia. Clinically, the changes of the periodontal tissue induced by the periodontitis progression were daily assessed. Two blood samples were obtained from each animal, at baseline and on completion of the experiment. The plasma level of the cytokine IL-6 and haematological parameters such as leukocytes, neutrophils, lymphocytes, monocytes, and platelets were determined. After seven days the animals were sacrificed, and samples were prepare...
Pertinent cell population to characterize periodontal disease
Tissue and Cell, 2009
The purpose of this in situ study is to quantify the inflammatory cell subsets and the area fraction (AA%) occupied by collagen fibers in human healthy and diseased (four different stages) gingival connective tissue in order to establish a possible correlation between periodontal disease resulting in collagen breakdown and specific inflammatory cell subsets.
Oral epithelium in the pathogenesis of periodontitis
2010
for their help and guidance in teaching me a range of key techniques used during my studies. My friends and colleagues Sally, Dominic, Lorraine, Keeley, Theresa & Jo have also offered lots of encouragement, and support during this study, as well as having to listen to all the moaning when my experiments went wrong! Contents: CHAPTER 1 Introduction PAGE NF-κB DNA binding 1.9.4 NF-κB gene transcription 1.9.5 Antioxidants 1.10 Antioxidants and periodontitis 1.11 α-lipoate 1.11.1 Direct radical scavenging 1.11.2 Redox interactions with other antioxidants 1.11.3 In-vitro antioxidant activity 1.11.4 Other biological actions of ALA and DHLA 1.12 Cytokines 1.12.1 Cytokines and periodontal disease 1.12.2 Interleukin 1 1.12.3 Interleukin 8 1.12.4 Tumour necrosis factor α 1.13 Aims and objectives CHAPTER 2 Materials and Methods PAGE 2.1 Bacterial inoculum preparation 2.1.1 Mycoplasma broth 2.
Are Cytokines Linked to Collagen Breakdown During Periodontal Disease Progression?
Journal of Periodontology, 2003
Background: Evidence of the role of cytokines produced by resident and inflammatory cells during inflammation is well established. The aim of this study was to quantify in healthy and diseased human gingiva the area fraction (AA%) occupied by collagen fibers and the amount of cytokines such as interleukin (IL)-1β, IL-4, IL-6, tumor necrosis factor (TNF)-α, transforming growth factor (TGF)-β, and epidermal growth factor (EGF) to investigate a possible correlation between such cytokines, collagen degradation, and the gingival index.
Critical Reviews in Oral Biology & Medicine, 1997
Fibroblasts have been studied extensively for their contribution to connective tissue destruction in diseases where the metabolism of extracellular matrix components plays an essential part in their pathogenesis. A considerable dissolution, especially of collagen fibrils, is a well-known characteristic of the periodontal ligament and the gingival connective tissue in microbial-induced periodontal disease. Fibroblasts, responsible for the assembly of the extracellular matrix, are capable of responding directly to oral microbial challenges or indirectly, following activation of the host immune response, and can alter the composition of connective tissue in several ways: synthesis of inflammatory mediators, their receptors and antagonists; fibroblast proliferation; collagen synthesis; phagocytosis of collagen fibrils; and synthesis of proteolytic enzymes, including matrix metalloproteinases and their corresponding inhibitors. The contributions of these cellular fibroblastic properties to the pathogenesis of periodontal disease are reviewed in the context of the cytokine, interleukin-l, as the inflammatory regulator. Key words. Periodontal disease, matrix metalloproteinases, interleukin-1 3, fibroblasts, collagen metabolism. 8(2) 217 236 (1997)G rit Rev Oral Biol Med 217 217 Crit Rev Oral Biol Med 8(2):217-236 (1997) Cr0 Rev Oral Bid Med